Free tool
FAERS Monitor: Carac
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020985 or its brand name (Carac, Fluorouracil). Reports on generic versions are filed under their own applications.
Reports
77,613
Serious
73,672
95% of reports
Hospitalization
31,279
Death reported
10,971
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea7,077
- neutropenia5,294
- nausea5,064
- vomiting4,038
- off label use3,620
- neuropathy peripheral3,541
- fatigue3,320
- disease progression3,293
- pyrexia3,085
- thrombocytopenia3,036
- febrile neutropenia2,915
- anaemia2,610
- asthenia2,589
- drug ineffective2,247
- malignant neoplasm progression2,217
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,695 |
| 2005 | 1,687 |
| 2006 | 1,392 |
| 2007 | 1,586 |
| 2008 | 1,848 |
| 2009 | 1,815 |
| 2010 | 1,692 |
| 2011 | 2,338 |
| 2012 | 2,862 |
| 2013 | 2,240 |
| 2014 | 1,878 |
| 2015 | 2,385 |
| 2016 | 2,753 |
| 2017 | 3,198 |
| 2018 | 4,845 |
| 2019 | 5,110 |
| 2020 | 4,266 |
| 2021 | 4,273 |
| 2022 | 5,711 |
| 2023 | 6,300 |
| 2024 | 5,981 |
| 2025 | 6,681 |
| 2026 | 5,077 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,546 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 2,915 | 12.4 | 12.0 | 29,318 |
| neutropeniaSignal | 5,294 | 10.9 | 10.7 | 46,232 |
| neuropathy peripheralSignal | 3,541 | 10.4 | 10.1 | 29,220 |
| disease progressionSignal | 3,293 | 7.7 | 7.5 | 18,855 |
| thrombocytopeniaSignal | 3,036 | 7.5 | 7.3 | 16,823 |
| malignant neoplasm progressionSignal | 2,217 | 6.0 | 5.7 | 9,022 |
| anaemiaSignal | 2,610 | 3.7 | 3.6 | 5,227 |
| diarrhoeaSignal | 7,077 | 3.0 | 2.9 | 9,581 |
| pyrexiaSignal | 3,085 | 2.4 | 2.3 | 2,612 |
| vomitingSignal | 4,038 | 2.3 | 2.3 | 3,137 |
| asthenia | 2,589 | 1.9 | 1.8 | 1,062 |
| nausea | 5,064 | 1.7 | 1.7 | 1,640 |
| fatigue | 3,320 | 1.2 | 1.1 | 72 |
| off label use | 3,620 | 1.1 | 1.1 | 49 |
| drug ineffective | 2,247 | 0.5 | 0.4 | 1,506 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.